HLA-A allele-lacking leukocytes (HLA-LLs) were detected in 25.4% of newly diagnosed patients with aplastic anemia.
The presence of HLA-LLs at diagnosis was strongly related to good clinical outcomes.
T-cell attacks against hematopoietic progenitor cells can trigger bone marrow failure.